Altered biological distribution and decreased neuromuscular toxicity of niosome encapsulated vincristine

Indian Journal of Experimental Biology

Volumn 34, Issue 2, 1996, Pages 124-130

  Parthasarathi, G ^a,d   Udupa, N ^a   Parameshwaraiah, N ^b   Pillai, G K ^c  

^a KASTURBA MEDICAL COLLEGE   (India)

^b JSS MEDICAL COLLEGE   (India)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^d JSS COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; NIOSOME; VINCRISTINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; ENCAPSULATION; ENZYME ACTIVITY; HISTOPATHOLOGY; ISOTOPE LABELING; MORBIDITY; MORTALITY; MOUSE; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CAPSULES; MICE; MICE, INBRED BALB C; NEUROMUSCULAR JUNCTION; RATS; RATS, WISTAR; VINCRISTINE;

EID: 0030020663     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. John J Mc Cormac, in The Alkaloids, Vol 37, edited by Arnold Broski (Academic Press Inc, New York) 1990, 229.
2. Johnson J S, Armstrong J G, Gorman M & Burnett J P, Cancer Res, 23 (1963) 1390.
3. Susan R & Sheldon K, Annals Internal Med, 80 (1974) 733.
4. Mayer L D, Ko D S C, Masin D, Gensberg R S, Cullis P R & Bally M B, Cancer Res, 49 (1989) 5922.
5. Parthasarathi G, Udupa N, Umadevi P & Pillai G K, J Drug Targeting, 2 (1994) 173.
6. Gabizon A, Cancer Res, 52 (1992) 891.
7. Rogerson A, Cummings J, Eillmott N, Florence A T, J Pharm Pharmacol, 40 (1988) 337.
8. Gabizon A & Pahadjopoulos D, Proc Natl Acad Sci USA, 85 (1988) 6949.
9. Derek L & Andre T, Eur J Cancer, 16 (1980) 945.
10. Baillie A J, Florence A T, Hume L R, Murihead G T, Rogerson A, J Pharm Pharmacol, 38 (1985) 863.
11. Parthasarathi G, Udupa N & Pillai G K, Indian J Pharm Sci, 56 (1994) 90.
12. Parthasarathi G, Targeting of selected anticancer drug using nonionic surfactant vesicles as drug carriers. Ph D thesis, Kasturba Medical College, Mangalore University, 1993.
13. Gabizon A, Chisin S, Anselem S, Druckmann R, Cohen D & Barenholtz Y, Br J Cancer, 64 (1991) 1125.
14. Zee-Cheng R K & Cheng C C, Meth Find Exp Clin Pharmacol, 11 (1989) 439.
15. Juliano R L & Stamp D, Biochem Pharmacol, 27 (1978) 21.
16. Harashima H, Ohima S, Midori Y, Yachi K, Kikuchi H & Kiwada H. Biopharm Drug disposit, 13 (1992) 155.
17. Haung S, Mayhew e, Cilami S, Lasic D D, Martin F J & Pahadjopoulous D, Cancer Res, 52 (1992) 1.
18. Finkelstein M C, Kadan S H, Scheinen H, Weismann G, Hoffstein S, Biochim Biophys Acta, 673 (1981) 286.
19. Hsu M J & Juliano R L, Ibid, 720 (1982) 411.
20. Gottschalk G, Dyek P J & Kiely J M, Neurology, 18 (1968) 875.
21. Bradley W G, J Neuro Sci, 10 (1970) 133.
22. William W S, J Neuropathol ExpNeurol, 30 (1971) 488.
23. Joe T R, George K, Stirling C & Leonard S W, J Neuropathol Exp Neurol, 31 (1972) 247.
24. Bradley W G, Lassman L P, Pearce G W & Walton J N, J Neurol Sci, 10 (1970) 107.
25. Yasin R, Parker J A& Hughes B P, Lab Invest, 29 (1973) 207.
26. Yasin R & Parker J A, Biochem Pharmacol, 24 (1975) 745.